4Vote M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood donor screening[J ]. N Engl J Med, 1999, 341(16): 866-870. 被引量：1
5Yoneyama K, Yamaguchi M, Kiuchi Y, et al. Analysis of background factors influencing long term prognosis of patients with chronic hepatitis C treated with interferon [J]. Intervirology,2002, 45(1): 11-19. 被引量：1
6Tong M, EI-Frra N S, Reikes A R, et al. Clinical outcomes after transfusion associated hepatitis C[J]. N Engl J Med, 1995,332(1): 1463 - 1466. 被引量：1
7Peterson J, Gteen G, Lida K, et al. Detection of hepatitis C core antigen in the antibody negative " window" phase of hepatitis C infection. Vox Sang, 2000,78 : 80-85. 被引量：1
8Lee SR, Pctcrson J, Nivcn P, ct al. Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of "window-phase" blood donations. Vox Sang,2001,80:19-23. 被引量：1
9Courouce AM, Marrec NL, Bouchardeau F, et al. Efficacy of HCV core antigen detection during the preset seroconvcrsion period. Transfusion, 2000,40:1198-1202. 被引量：1
